{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:54:14Z","timestamp":1791665654971,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2718,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1111\/jth.12952","type":"journal-article","created":{"date-parts":[[2015,6,21]],"date-time":"2015-06-21T08:15:36Z","timestamp":1434874536000},"page":"S10-S16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"special_numbering":"S1","title":["P2Y12 receptors: structure and function"],"prefix":"10.1016","volume":"13","author":[{"given":"M.","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12952_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11302-011-9216-0","article-title":"Pharmacochemistry of the platelet purinergic receptors","volume":"7","author":"Jacobson","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1111\/jth.12952_bb0015","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1161\/01.ATV.19.10.2281","article-title":"ADP receptors and clinical bleeding disorders","volume":"19","author":"Cattaneo","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12952_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2005-869518","article-title":"Platelet aggregation and adenosine diphosphate\/adenosine triphosphate receptors: a historical perspective","volume":"31","author":"Packham","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12952_bb0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2005-869522","article-title":"The P2 receptors and congenital platelet function defects","volume":"31","author":"Cattaneo","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12952_bb0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V75.5.1081.1081","article-title":"Released adenosine diphosphate stabilizes thrombin\u2010induced human platelet aggregates","volume":"75","author":"Cattaneo","year":"1990","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0038-1642389","article-title":"Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin","volume":"71","author":"Cattaneo","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0040","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood.V94.12.4156","article-title":"A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1\u2010activating peptide through the late activation of phosphoinositide 3\u2010kinase","volume":"94","author":"Trumel","year":"1999","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0045","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/01.ATV.0000092127.16125.E6","article-title":"Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity","volume":"23","author":"Leon","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12952_bb0050","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1152\/ajplegacy.1975.228.6.1757","article-title":"Factors responsible for ADP\u2010induced release reaction of human platelets","volume":"228","author":"Mustard","year":"1975","journal-title":"Am J Physiol"},{"key":"10.1111\/jth.12952_bb0055","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1182\/blood-2002-01-0313","article-title":"Adenosine diphosphate (ADP) does not induce thromboxane A2 generation in human platelets","volume":"99","author":"Cattaneo","year":"2002","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-0029-1220324","article-title":"Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function","volume":"35","author":"Cattaneo","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12952_bb0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0038-1649591","article-title":"The in\u00a0vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionised calcium","volume":"70","author":"Falcon","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0070","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0026-895X(24)12604-1","article-title":"Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor","volume":"60","author":"Takasaki","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jth.12952_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1111\/jth.12952_bb0080","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1074\/jbc.M009718200","article-title":"ADP is the cognate ligand for the orphan G protein\u2010coupled receptor SP1999","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12952_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11302-012-9329-0","article-title":"The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB\u20100413","volume":"9","author":"Ohlmann","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1111\/jth.12952_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/jpet.111.184143","article-title":"A clopidogrel\u2010insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct\u2010acting, reversible P2Y12 antagonist","volume":"339","author":"Haberstock\u2010Debic","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jth.12952_bb0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature13288","article-title":"Agonist\u2010bound structure of the human P2Y12 receptor","volume":"509","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1111\/jth.12952_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature13083","article-title":"Structure of the human P2Y12 receptor in complex with an antithrombotic drug","volume":"509","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1111\/jth.12952_bb0105","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2010-08-263111","article-title":"The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug\u2010induced defects","volume":"117","author":"Cattaneo","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1742-4658.2011.08410.x","article-title":"Identification and analysis of functionally important amino acids in human purinergic 12 receptor using a Saccharomyces cerevisiae expression system","volume":"279","author":"Ignatovica","year":"2012","journal-title":"FEBS J"},{"key":"10.1111\/jth.12952_bb0115","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.bcp.2008.08.029","article-title":"Involvement of basic aminoacid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)\u2010receptor","volume":"76","author":"Hoffmann","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/jth.12952_bb0120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1124\/mol.64.5.1210","article-title":"Purification and functional reconstitution of the human P2Y12 receptor","volume":"64","author":"Bodor","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jth.12952_bb0125","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1538-7836.2005.01325.x","article-title":"Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP\u2010mediated platelet activation","volume":"3","author":"Quinton","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00001721-199603000-00035","article-title":"cAMP is not an important messenger for ADP\u2010induced platelet aggregation","volume":"7","author":"Savi","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12952_bb0135","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1055\/s-0037-1614384","article-title":"Role of intracellular signaling events in ADP\u2010induced platelet aggregation","volume":"82","author":"Daniel","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1538-7836.2007.02356.x","article-title":"Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin","volume":"5","author":"Cattaneo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0145","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8399","article-title":"Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor\u2010null mice","volume":"104","author":"Leon","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12952_bb0150","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/13522","article-title":"Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1\u2010deficient mice","volume":"5","author":"Fabre","year":"1999","journal-title":"Nat Med"},{"key":"10.1111\/jth.12952_bb0155","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI12242","article-title":"Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs","volume":"107","author":"Foster","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12952_bb0160","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood.V96.10.3439","article-title":"FcgammaRIIA requires a Gi\u2010dependent pathway for an efficient stimulation of phosphoinositide 3\u2010kinase, calcium mobilization, and platelet aggregation","volume":"96","author":"Gratacap","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.bjp.0703046","article-title":"ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors","volume":"129","author":"Jarvis","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.12952_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0014-5793(01)02824-1","article-title":"The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin\u2013a phosphoinositide 3\u2010kinase\u2010dependent mechanism","volume":"505","author":"Kauffenstein","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1111\/jth.12952_bb0175","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1096\/fj.00-0810fje","article-title":"Resistance to thromboembolism in PI3Kgamma\u2010deficient mice","volume":"15","author":"Hirsch","year":"2001","journal-title":"FASEB J"},{"key":"10.1111\/jth.12952_bb0180","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1074\/jbc.M306162200","article-title":"Akt activation in platelets depends on Gi signaling pathways","volume":"279","author":"Kim","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12952_bb0185","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1538-7836.2006.01941.x","article-title":"Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation","volume":"4","author":"Kamae","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0190","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1182\/blood-2009-04-218768","article-title":"CalDAG\u2010GEFI is at the nexus of calcium\u2010dependent platelet activation","volume":"114","author":"Stefanini","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0195","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1538-7836.2004.00926.x","article-title":"Adenine triphosphate nucleotides are antagonists at the P2Y receptor","volume":"2","author":"Kauffenstein","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2009.11.006","article-title":"Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors","volume":"125","author":"Chang","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12952_bb0205","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1161\/01.ATV.20.11.e101","volume":"20","author":"Cattaneo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12952_bb0210","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1055\/s-0038-1656090","volume":"77","author":"Cattaneo","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0215","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-0037-1615655","article-title":"Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation","volume":"85","author":"Eckly","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.ATV.13.3.393","article-title":"Shear\u2010induced platelet aggregation is potentiated by desmopressin (DDAVP) and inhibited by ticlopidine","volume":"13","author":"Cattaneo","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/jth.12952_bb0225","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1365-2141.1994.tb05123.x","article-title":"Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP","volume":"88","author":"Cattaneo","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12952_bb0230","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.0000016703.93845.AF","article-title":"Functional significance of adenosine 5\u2032\u2010diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate","volume":"105","author":"Goto","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/jth.12952_bb0235","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/blood.V98.12.3340","article-title":"Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow","volume":"98","author":"Turner","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0240","doi-asserted-by":"crossref","first-page":"e10130","DOI":"10.1371\/journal.pone.0010130","article-title":"Stabilizing role of platelet P2Y(12) receptors in shear\u2010dependent thrombus formation on ruptured plaques","volume":"5","author":"Nergiz\u2010Unal","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.12952_bb0245","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1538-7836.2004.00692.x","article-title":"Role of protease\u2010activated and ADP receptor subtypes in thrombin generation on human platelets","volume":"2","author":"Dorsam","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0250","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1160\/TH04-09-0597","article-title":"Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk","volume":"93","author":"van der Meijden","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0255","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/ATVBAHA.110.213702","article-title":"Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions","volume":"30","author":"Rauch","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12952_bb0260","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.ATV.0000142376.30582.ed","article-title":"ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels","volume":"24","author":"Wihlborg","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12952_bb0265","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.4049\/jimmunol.0901799","article-title":"Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP","volume":"185","author":"Ben Addi","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/jth.12952_bb0270","doi-asserted-by":"crossref","first-page":"ra55","DOI":"10.1126\/scisignal.2000588","article-title":"Autocrine purinergic receptor signaling is essential for macrophage chemotaxis","volume":"3","author":"Kronlage","year":"2010","journal-title":"Sci Signal"},{"key":"10.1111\/jth.12952_bb0275","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00395-009-0073-8","article-title":"Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes","volume":"105","author":"Diehl","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1111\/jth.12952_bb0280","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI38576","article-title":"The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling","volume":"122","author":"Su","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12952_bb0285","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.4049\/jimmunol.178.12.8127","article-title":"Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury","volume":"178","author":"Eckle","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/jth.12952_bb0290","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09537100020031207","article-title":"Platelet CD40 ligand (CD40L)\u2013subcellular localization, regulation of expression, and inhibition by clopidogrel","volume":"12","author":"Hermann","year":"2001","journal-title":"Platelets"},{"key":"10.1111\/jth.12952_bb0295","series-title":"Platelets","first-page":"1117","article-title":"ADP receptor antagonists","author":"Cattaneo","year":"2013"},{"key":"10.1111\/jth.12952_bb0300","article-title":"The platelet P2 receptors in inflammation","volume":"35","author":"Cattaneo","year":"2015","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.12952_bb0305","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1365-2222.2012.03982.x","article-title":"Cysteinyl leukotriene receptors, old and new; implications for asthma","volume":"42","author":"Laidlaw","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/jth.12952_bb0310","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4\u2010induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"J Exp Med"},{"issue":"Suppl. 1","key":"10.1111\/jth.12952_bb0315","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1111\/jth.12779","article-title":"Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double\u2010blind, placebo\u2010controlled, cross\u2010over study","volume":"13","author":"Lussana","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0320","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ijc.28997","article-title":"Inhibition of platelet activation prevents the P\u2010selectin and integrin\u2010dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in\u00a0vivo","volume":"136","author":"Mezouar","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1111\/jth.12952_bb0325","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ijc.28947","article-title":"The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer","volume":"136","author":"Gebremeskel","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1111\/jth.12952_bb0330","doi-asserted-by":"crossref","first-page":"e80780","DOI":"10.1371\/journal.pone.0080780","article-title":"Platelet P2Y12 is involved in murine pulmonary metastasis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.12952_bb0335","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V80.11.2787.2787","article-title":"Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate","volume":"80","author":"Cattaneo","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0340","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1182\/blood-2008-11-190850","article-title":"Identification and characterization of a novel P2Y12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM\u20101VWD study","volume":"113","author":"Daly","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0345","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1182\/blood-2011-02-336826","article-title":"An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets","volume":"118","author":"Nisar","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0350","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/jth.12539","article-title":"A novel mutation in the P2Y12 receptor and a function\u2010reducing polymorphism in protease\u2010activated receptor 1 in a patient with chronic bleeding","volume":"12","author":"Patel","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0355","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2013-07-517896","article-title":"Identification of a new dysfunctional platelet P2Y12 receptor variant, associated with bleeding diathesis","volume":"125","author":"Lecchi","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.12952_bb0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y(12) inhibitors","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/jth.12952_bb0365","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1538-7836.2011.04602.x","article-title":"Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?","volume":"10","author":"Cattaneo","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12952_bb0370","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard\u2010 vs high\u2010dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/jth.12952_bb0375","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12952_bb0380","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","article-title":"Adenosine\u2010mediated effects of ticagrelor: evidence and potential clinical relevance","volume":"63","author":"Cattaneo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12952_bb0385","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH12-08-0547","article-title":"Why does ticagrelor induce dyspnea?","volume":"108","author":"Cattaneo","year":"2012","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12952","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12952","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362204243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362204243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12952\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:13:42Z","timestamp":1761534822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362204243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":76,"alternative-id":["S153878362204243X"],"URL":"https:\/\/doi.org\/10.1111\/jth.12952","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12 receptors: structure and function","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}